Patents by Inventor Jean-Paul Prieels

Jean-Paul Prieels has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INACTIVATED DENGUE VIRUS VACCINE WITH ALUMINIUM-FREE ADJUVANT
    Publication number: 20160120972
    Abstract: The present disclosure provides immunogenic compositions for the prevention and/or treatment of disease caused by dengue virus.
    Type: Application
    Filed: January 11, 2016
    Publication date: May 5, 2016
    Inventors: Benoit BARAS, Dirk GHEYSEN, Isabelle Solange Lucie KNOTT, Jean-Paul PRIEELS, Jean-Francois TOUSSAINT
  • Inactivated dengue virus vaccine with aluminium-free adjuvant
    Patent number: 9265821
    Abstract: The present disclosure provides immunogenic compositions for the prevention and/or treatment of disease caused by dengue virus.
    Type: Grant
    Filed: February 16, 2010
    Date of Patent: February 23, 2016
    Assignee: GlaxoSmithKline Biologicals SA
    Inventors: Benoit Baras, Dirk Gheysen, Isabelle Solange Lucie Knott, Jean-Paul Prieels, Jean-Francois Toussaint
  • Vaccine
    Patent number: 9168313
    Abstract: The present invention relates to the field of bacterial polysaccharide antigen vaccines. In particular, the present invention relates to bacterial polysaccharides conjugated to protein D from H. influenzae.
    Type: Grant
    Filed: November 21, 2014
    Date of Patent: October 27, 2015
    Assignee: GLAXOSMITHKLINE BIOLOGICALS S.A.
    Inventors: Carine Capiau, Pierre Michel Desmons, Craig Antony Joseph Laferriere, Jan Poolman, Jean-Paul Prieels
  • VACCINE
    Publication number: 20150079125
    Abstract: The present invention relates to the field of bacterial polysaccharide antigen vaccines. In particular, the present invention relates to bacterial polysaccharides conjugated to protein D from H. influenzae.
    Type: Application
    Filed: November 21, 2014
    Publication date: March 19, 2015
    Inventors: Carine CAPIAU, Marguerite DESCHAMPS, Pierre Michel DESMONS, Craig Antony Joseph LAFERRIERE, Jan POOLMAN, Jean-Paul PRIEELS
  • VACCINE
    Publication number: 20150079129
    Abstract: The present invention relates to the field of bacterial polysaccharide antigen vaccines. In particular, the present invention relates to bacterial polysaccharides conjugated to protein D from H. influenzae.
    Type: Application
    Filed: November 21, 2014
    Publication date: March 19, 2015
    Inventors: Carine CAPIAU, Marguerite DESCHAMPS, Pierre Michel DESMONS, Craig Antony Joseph LAFERRIERE, Jan POOLMAN, Jean-Paul PRIEELS
  • Vaccine
    Patent number: 8926985
    Abstract: The present invention relates to the field of bacterial polysaccharide antigen vaccines. In particular, the present invention relates to bacterial polysaccharides conjugated to protein D from H. influenzae.
    Type: Grant
    Filed: November 5, 2009
    Date of Patent: January 6, 2015
    Assignee: GlaxoSmithKline Biologicals S A
    Inventors: Carine Capiau, Marguerite Deschamps, Pierre Michel Desmons, Craig Antonyjoseph Laferriere, Jan Poolman, Jean-Paul Prieels
  • IMMUNOGENIC COMPOSITIONS AND METHODS FOR TREATING NUEROLOGIC DISORDERS
    Publication number: 20130216614
    Abstract: The present invention relates to methods and compositions for preventing and reducing amyloid deposition in a subject by administering to the subject a composition containing aTLR4 agonist free of endotoxin, where the composition does not contain beta amyloid.
    Type: Application
    Filed: October 27, 2011
    Publication date: August 22, 2013
    Applicant: Glaxosmithkline Biologicals S.A.
    Inventors: Maxime Halle, Daniel Larocque, Remi Palmantier, Jean-Paul Prieels, Pascale Tribout-Jover
  • VACCINE
    Publication number: 20120189654
    Abstract: The present invention is in the field of pneumococcal capsular saccharide conjugate vaccines. Specifically, a multivalent Streptococcus pneumoniae immunogenic composition is provided with various (for instance 9 or more) conjugated capsular saccharides from different S. pneumoniae serotypes, wherein the composition comprises conjugated capsular saccharide 18C which is less than 80, 70, 60, 50, 40, 30, 20, 15 or 10% O-Acetylated.
    Type: Application
    Filed: December 22, 2011
    Publication date: July 26, 2012
    Applicant: GLAXOSMITHKLINE BIOLOGICALS, S.A.
    Inventors: Ralph Leon Biemans, Philippe Denoel, Jan Poolman, Jean Paul Prieels
  • INACTIVATED DENGUE VIRUS VACCINE WITH ALUMINIUM-FREE ADJUVANT
    Publication number: 20110318407
    Abstract: The present disclosure provides immunogenic compositions for the prevention and/or treatment of disease caused by dengue virus.
    Type: Application
    Filed: February 16, 2010
    Publication date: December 29, 2011
    Inventors: Benoit Baras, Dirk Gheysen, Isabelle Solange Lucie Knott, Jean-Paul Prieels, Jean-Francois Toussaint
  • Vaccine
    Publication number: 20110217329
    Abstract: The present invention relates to the field of bacterial polysaccharide antigen vaccines. In particular, the present invention relates to vaccines comprising a pneumococcal polysaccharide antigen, typically a pneumococcal polysaccharide conjugate antigen, formulated with a protein antigen form Streptococcus pneumoniae, and optionally a Th1-inducing adjuvant.
    Type: Application
    Filed: December 21, 2010
    Publication date: September 8, 2011
    Inventors: Carine CAPIAU, Marguerite Deschamps, Pierre Michel Desmons, Craig Antonyjoseph Laferriere, Jan Poolman, Jean-Paul Prieels
  • Vaccine
    Publication number: 20100291138
    Abstract: The present invention relates to the field of bacterial polysaccharide antigen vaccines. In particular, the present invention relates to vaccines comprising a pneumococcal polysaccharide antigen, typically a pneumococcal polysaccharide conjugate antigen, formulated with a protein antigen form Streptococcus pneumoniae, and optionally a Th1-inducing adjuvant.
    Type: Application
    Filed: June 3, 2010
    Publication date: November 18, 2010
    Inventors: Carine Capiau, Marguerite Deschamps, Pierre Michel Desmons, Craig Antonyjoseph Laferriere, Jan Poolman, Jean-Paul Prieels
  • VACCINE
    Publication number: 20100119544
    Abstract: The present invention relates to the field of bacterial polysaccharide antigen vaccines. In particular, the present invention relates to bacterial polysaccharides conjugated to protein D from H. influenzae.
    Type: Application
    Filed: November 5, 2009
    Publication date: May 13, 2010
    Inventors: Carine Capiau, Marguerite Deschamps, Pierre Michel Desmons, Craig Antonyjoseph Laferriere, Jan Poolman, Jean-Paul Prieels
  • VACCINE
    Publication number: 20090162394
    Abstract: The present invention is in the field of pneumococcal capsular saccharide conjugate vaccines. Specifically, a multivalent Streptococcus pneumoniae immunogenic composition is provided with various (for instance 9 or more) conjugated capsular saccharides from different S. pneumoniae serotypes, wherein the composition comprises conjugated capsular saccharide 18C which is less than 80, 70, 60, 50, 40, 30, 20, 15 or 10% O-Acetylated.
    Type: Application
    Filed: April 5, 2007
    Publication date: June 25, 2009
    Inventors: Ralph Leon Biemans, Philippe Denoel, Jan Poolman, Jean Paul Prieels
  • CHLAMYDIA VACCINES
    Publication number: 20080102112
    Abstract: Vaccine preparations are provided for the prevention of Chlamydia infections comprising a major outer membrane protein from chlamydia and a mucosal adjuvant such as a combination of QS21 and 3D-MPL, or chlorea Toxin or Heat labile enterotoxin. Such preparations provide protection from Chlamydia induced fertility.
    Type: Application
    Filed: October 29, 2007
    Publication date: May 1, 2008
    Inventors: Jean-Francois MAISONNEUVE, Jean-Paul Prieels, Moncef-Mohamed Slaoui, Vincent Georges Verlant
  • Vaccine composition containing adjuvants
    Patent number: 7147862
    Abstract: The present invention provides vaccine compositions comprising 3 De-O-acylated monophosphoryl lipid A and QS21. The vaccines compositions are potent inducers of CTL and ? IFN responses.
    Type: Grant
    Filed: August 12, 1997
    Date of Patent: December 12, 2006
    Assignee: SmithKline Beecham Biologicals (S.A.)
    Inventors: Jean-Paul Prieels, Nathalie Marie-Josephe Claude Garcon-Johnson, Moncef Slaoui, Pietro Pala
  • Vaccine
    Publication number: 20060093626
    Abstract: The present invention relates to the field of bacterial polysaccharide antigen vaccines. In particular the present invention relates to specific advantageous pneumococcal polysaccharide conjugates adjuvanted with 3D-MPL and substantially devoid of aluminium-based adjuvant.
    Type: Application
    Filed: September 30, 2005
    Publication date: May 4, 2006
    Inventors: Carine Capiau, Marguerite Deschamps, Pierre Desmons, Craig Laferriere, Jan Poolman, Jean-Paul Prieels
  • Vaccine
    Publication number: 20060002961
    Abstract: The present invention relates to the field of bacterial polysaccharide antigen vaccines. In particular, the present invention relates to vaccines comprising a pneumococcal polysaccharide antigen, typically a pneumococcal polysaccharide conjugate antigen, formulated with a protein antigen form Streptococcus pneumoniae, and optionally a Th1-inducing adjuvant.
    Type: Application
    Filed: August 31, 2005
    Publication date: January 5, 2006
    Inventors: Carine Capiau, Marguerite Deschamps, Pierre Desmons, Craig Laferriere, Jan Poolman, Jean-Paul Prieels
  • Chylamydia vaccine
    Publication number: 20050208123
    Abstract: Vaccine preparations are provided for the prevention of Chylamydia infections comprising a major outer membrane protein from chlamydia and a mucosal adjuvant such as a combination of QS21 and 3D-MPL, or chlorea Toxin or Heat labile enterotoxin. Such preparations provide protection from Chlamydia induced infertility.
    Type: Application
    Filed: March 24, 2005
    Publication date: September 22, 2005
    Inventors: Jean-Francois Maisonneuve, Jean-Paul Prieels, Moncef-Mohamed Slaoui, Vincent Louis Verlant
  • Vaccine
    Publication number: 20050031646
    Abstract: The present invention relates to the field of bacterial polysaccharide antigen vaccines. In particular, the present invention relates to bacterial polysaccharides conjugated to protein D from H influenzae.
    Type: Application
    Filed: August 27, 2004
    Publication date: February 10, 2005
    Inventors: Carine Capiau, Marguerite Deschamps, Pierre Desmons, Craig Laferriere, Jan Poolman, Jean-Paul Prieels
  • Vaccines
    Publication number: 20030219453
    Abstract: Vaccine preparations are provided for the prevention of Chylamydia infections comprising a major outer membrane protein from chlamydia and a mucosal adjuvant such as a combination of QS21 and 3D-MPL, or chlorea Toxin or Heat labile enterotoxin. Such preparations provide protection from Chlamydia induced fertility.
    Type: Application
    Filed: November 6, 2002
    Publication date: November 27, 2003
    Applicant: SmithKline Beecham Biologicals, sa
    Inventors: Jean-Francois Lucien Maisonneuve, Jean-Paul Prieels, Moncef-Mohamed Slaoui, Vincent Georges Christian Louis Verlant